标题
Impaired brain insulin signalling in Parkinson's disease
作者
关键词
-
出版物
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-08-18
DOI
10.1111/nan.12760
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson’s Disease
- (2020) Lingyu Zhang et al. Journal of Parkinsons Disease
- Insulin Sensitivity in De Novo Parkinson's Disease: A Hyperinsulinemic‐Euglycemic Clamp Study
- (2020) N. Ahmad Aziz et al. MOVEMENT DISORDERS
- Peripheral insulin and amylin levels in Parkinson's disease
- (2020) Almudena Sánchez-Gómez et al. PARKINSONISM & RELATED DISORDERS
- GLP-1’s role in neuroprotection: a systematic review
- (2019) Damla Erbil et al. BRAIN INJURY
- Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
- (2018) Seung Pil Yun et al. NATURE MEDICINE
- High Prevalence of Undiagnosed Insulin Resistance in Non-Diabetic Subjects with Parkinson’s Disease
- (2018) Elliot Hogg et al. Journal of Parkinsons Disease
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- Brain Insulin-Like Growth Factor and Neurotrophin Resistance in Parkinson's Disease and Dementia with Lewy Bodies: Potential Role of Manganese Neurotoxicity
- (2017) Ming Tong et al. JOURNAL OF ALZHEIMERS DISEASE
- Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy
- (2016) Michel Engeln et al. NEUROPHARMACOLOGY
- Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer’s disease
- (2015) Dimitrios Kapogiannis et al. FASEB JOURNAL
- Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling
- (2015) Shanshan Gao et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
- (2015) Mojtaba Golpich et al. PHARMACOLOGICAL RESEARCH
- Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
- (2015) Iciar Aviles-Olmos et al. Journal of Parkinsons Disease
- Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression
- (2015) Mathieu Bourdenx et al. Acta Neuropathologica Communications
- Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer’s disease and tauopathies
- (2014) Mark Yarchoan et al. ACTA NEUROPATHOLOGICA
- Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
- (2014) Fares Bassil et al. PROGRESS IN NEUROBIOLOGY
- Levodopa gains psychostimulant-like properties after nigral dopaminergic loss
- (2013) Michel Engeln et al. ANNALS OF NEUROLOGY
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s disease
- (2013) Marina Picillo et al. JOURNAL OF NEUROLOGY
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
- (2012) Theresa R. Bomfim et al. JOURNAL OF CLINICAL INVESTIGATION
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
- (2012) Konrad Talbot et al. JOURNAL OF CLINICAL INVESTIGATION
- 100 years of Lewy pathology
- (2012) Michel Goedert et al. Nature Reviews Neurology
- Serum Insulinlike Growth Factor 1 as Possible Marker for Risk and Early Diagnosis of Parkinson Disease
- (2011) Jana Godau ARCHIVES OF NEUROLOGY
- Direct Interaction of α-Synuclein and AKT Regulates IGF-1 Signaling: Implication of Parkinson Disease
- (2011) Ji-Yun Chung et al. NEUROSIGNALS
- Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson’s disease
- (2010) Farhad Mashayekhi et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease
- (2010) J. Godau et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pathogenic Lysosomal Depletion in Parkinson's Disease
- (2010) B. Dehay et al. JOURNAL OF NEUROSCIENCE
- Insulin like growth factor-1 prevents 1-mentyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3beta
- (2010) Xin Sun et al. TOXICOLOGY
- Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps
- (2009) Oren A. Levy et al. APOPTOSIS
- Rescue of α-synuclein cytotoxicity by insulin-like growth factors
- (2009) Shyan-Yuan Kao BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dopamine promotes striatal neuronal apoptotic death via ERK signaling cascades
- (2009) Jun Chen et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
- (2009) Yaping Chu et al. NEUROBIOLOGY OF DISEASE
- PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease
- (2008) Arnulfo Quesada et al. Developmental Neurobiology
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
- (2008) Aileen M. Moloney et al. NEUROBIOLOGY OF AGING
- Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease
- (2007) Allison D. Ebert et al. EXPERIMENTAL NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search